• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ SMALL; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ SMALL; INTRODUCER, CATHETER Back to Search Results
Model Number D138501
Device Problem Material Separation (1562)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/28/2022
Event Type  malfunction  
Event Description
It was reported that a patient underwent a cardiac ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿ small and a hemostatic valve separation issue occurred.It was reported that the device was unable to flush due to dislodgement of the hemostatic valve.The event occurred when the sheath was into the inguinal canal.The issue was resolved by changing the vizgo to another one.The procedure was successfully completed.No adverse patient consequence was reported.The hemostatic valve separation issue is mdr reportable.
 
Manufacturer Narrative
(b)(6).The biosense webster, inc.Product analysis lab received the device for evaluation.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
Additional information was received on 29-nov-2022.There was no damage except for hemostatic valve dislodgement.Hemostatic valve was dislodged inside the hub but not outside the hub.The brim cap/hub did not detach from the sheath.No picture available.Sheath was used on the patient.No treatment required.There was no reflux of blood.The device evaluation was completed on 09-nov-2022.The carto vizigo¿ 8.5f bi-directional guiding sheath ¿ small product was returned to biosense webster for evaluation.Bwi then conducted a visual inspection and a functional test of the side port.Visual analysis of the returned sample revealed that no damage was observed on the vizigo¿ sheath.The returned sample was connected to a syringe with water and no leakage was observed.In addition, the functional test of the side port was performed, and no issues were observed.A device history record (dhr) evaluation was performed for the finished device 00002014 number, and no internal action related to the complaint was found during the review.Based on the dhr, the h4.Device manufacture date has been updated.The hemostatic valve dislodged reported by the customer was not confirmed as the device was returned without detectable damage.Although no product defect was identified, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the laboratory analysis.The odp contains the following caution: always insert a dilator straight into the center of the sheath¿s valve to prevent damage to the valve.Do not insert a dilator at an angle, as damage to the sheath valve may occur.As part of the quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ SMALL
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (IRVINE)
33 technology drive
irvine CA 92618
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key15671906
MDR Text Key307005601
Report Number2029046-2022-02645
Device Sequence Number1
Product Code DYB
UDI-Device Identifier10846835016253
UDI-Public10846835016253
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K170997
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2023
Device Model NumberD138501
Device Catalogue NumberD138501
Device Lot Number00002014
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/21/2022
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 09/28/2022
Initial Date FDA Received10/26/2022
Supplement Dates Manufacturer Received11/09/2022
Supplement Dates FDA Received12/08/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/31/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNK_CARTO VIZIGO SHEATH
-
-